[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
3 Unprofitable Stocks That Concern Us

3 Unprofitable Stocks That Concern Us

HTLD : 15.51 (+1.51%)
PACB : 1.6500 (+3.12%)
CNC : 65.73 (+1.48%)
Q1 Earnings Highs And Lows: PacBio (NASDAQ:PACB) Vs The Rest Of The Life Sciences Tools & Services Stocks

Q1 Earnings Highs And Lows: PacBio (NASDAQ:PACB) Vs The Rest Of The Life Sciences Tools & Services Stocks

PACB : 1.6500 (+3.12%)
3 Russell 2000 Stocks Walking a Fine Line

3 Russell 2000 Stocks Walking a Fine Line

ATLC : 110.41 (+1.98%)
PACB : 1.6500 (+3.12%)
BOH : 81.99 (+0.26%)
PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing

MENLO PARK, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced that SPRQ-Nx sequencing chemistry and new...

PACB : 1.6500 (+3.12%)
PacBio to Participate in the Jefferies Global Healthcare Conference 

MENLO PARK, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate...

PACB : 1.6500 (+3.12%)
Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology

Collaboration with PacBio will generate long-read bulk RNA-seq data to advance patient-level prediction from tumor transcriptomes

PACB : 1.6500 (+3.12%)
1 Stock Under $10 to Keep an Eye On and 2 We Avoid

1 Stock Under $10 to Keep an Eye On and 2 We Avoid

FRSH : 9.85 (+7.42%)
PACB : 1.6500 (+3.12%)
ASLE : 6.55 (+1.55%)
HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss

MENLO PARK, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the publication of a preprint describing...

PACB : 1.6500 (+3.12%)
Why PacBio (PACB) Shares Are Getting Obliterated Today

Why PacBio (PACB) Shares Are Getting Obliterated Today

PACB : 1.6500 (+3.12%)
PACB Q1 Deep Dive: Consumables Growth and Clinical Adoption Offset Instrument Weakness

PACB Q1 Deep Dive: Consumables Growth and Clinical Adoption Offset Instrument Weakness

PACB : 1.6500 (+3.12%)

Barchart Exclusives

Tesla Left a Big Hole in Short Sellers’ Pockets. It’s SpaceX’s Turn Now.
Short-sellers lost billions of dollars betting against Tesla over the last decade. Can SpaceX also be a short-seller killer like TSLA? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.